Differences in Hematological and Clinical Features Between Essential Thrombocythemia Cases With JAK2- or CALR-Mutations

Ann Lab Med. 2017 Mar;37(2):159-161. doi: 10.3343/alm.2017.37.2.159.

Authors

Yoko Kubuki^{1

2}, Kotaro Shide², Takuro Kameda², Takumi Yamaji², Masaaki Sekine², Ayako Kamiunten², Keiichi Akizuki², Haruko Shimoda^{1

2}, Yuki Tahira², Kenichi Nakamura², Hiroo Abe², Tadashi Miike², Hisayoshi Iwakiri², Yoshihiro Tahara^{2

3}, Mitsue Sueta², Kanna Hashimoto², Shojiro Yamamoto², Satoru Hasuike², Tomonori Hidaka^{2

3}, Kenji Nagata^{2

4}, Akira Kitanaka², Kazuya Shimoda⁵

Affiliations

¹ Department of Transfusion and Cell Therapy, University of Miyazaki Hospital, Miyazaki, Japan.
² Department of Gastroenterology and Hematology, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan.
³ Oncology Unit, University of Miyazaki Hospital, Miyazaki, Japan.
⁴ Liver Disease Center, University of Miyazaki Hospital, Miyazaki, Japan.
⁵ Department of Gastroenterology and Hematology, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan. [email protected].

No abstract available

Publication types

Letter

MeSH terms

Adolescent
Adult
Age Factors
Aged
Aged, 80 and over
Amino Acid Sequence
Calreticulin / genetics*
Child
DNA / chemistry
DNA / genetics
DNA / metabolism
Exons
Female
Humans
Janus Kinase 2 / genetics*
Male
Middle Aged
Molecular Sequence Data
Polymorphism, Single Nucleotide
Receptors, Thrombopoietin / genetics
Sequence Analysis, DNA
Sex Factors
Thrombocythemia, Essential / diagnosis*
Thrombocythemia, Essential / genetics
Young Adult

Substances

Calreticulin
Receptors, Thrombopoietin
MPL protein, human
DNA
JAK2 protein, human
Janus Kinase 2